Canada Oncology NGS Market (2025-2031) | Size & Revenue, Industry, Forecast, Analysis, Value, Share, Growth, Segmentation, Trends, Competitive Landscape, Outlook, Companies

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Canada Country Macro Economic Indicators

3.2 Canada Oncology NGS Market Revenues & Volume, 2021 & 2031F

3.3 Canada Oncology NGS Market - Industry Life Cycle

3.4 Canada Oncology NGS Market - Porter's Five Forces

3.5 Canada Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 Canada Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 Canada Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F

3.8 Canada Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.9 Canada Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing incidence of cancer cases in Canada

4.2.2 Growing adoption of precision medicine in oncology

4.2.3 Technological advancements in next-generation sequencing (NGS) technologies

4.2.4 Rising demand for personalized treatment options

4.2.5 Supportive government initiatives and funding for oncology research

4.3 Market Restraints

4.3.1 High cost associated with NGS technologies and tests

4.3.2 Limited reimbursement policies for NGS-based oncology tests

4.3.3 Data privacy and security concerns related to genomic data

4.3.4 Lack of skilled professionals in the field of oncology NGS

4.3.5 Regulatory challenges and stringent approval processes for NGS-based tests

6.1 Canada Oncology NGS Market, By Technology

6.1.1 Overview and Analysis

6.1.2 Canada Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 Canada Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.1.4 Canada Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.2 Canada Oncology NGS Market, By Application

6.2.1 Overview and Analysis

6.2.2 Canada Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F

6.2.3 Canada Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F

6.3 Canada Oncology NGS Market, By Service

6.3.1 Overview and Analysis

6.3.2 Canada Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F

6.3.3 Canada Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F

6.4 Canada Oncology NGS Market, By Workflow

6.4.1 Overview and Analysis

6.4.2 Canada Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F

6.4.3 Canada Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F

6.4.4 Canada Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F

6.5 Canada Oncology NGS Market, By End-use

6.5.1 Overview and Analysis

6.5.2 Canada Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F

6.5.3 Canada Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F

6.5.4 Canada Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F

6.5.5 Canada Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F

6.5.6 Canada Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F

7.1 Canada Oncology NGS Market Export to Major Countries

7.2 Canada Oncology NGS Market Imports from Major Countries

8.1 Average turnaround time for NGS-based oncology tests

8.2 Number of research collaborations between industry players and academic institutions

8.3 Adoption rate of NGS technologies in oncology clinics

8.4 Rate of increase in the number of oncology NGS tests offered

8.5 Patient satisfaction scores related to the accuracy and efficacy of NGS-based oncology tests

9.1 Canada Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 Canada Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 Canada Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F

9.4 Canada Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.5 Canada Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 Canada Oncology NGS Market Revenue Share, By Companies, 2024

10.2 Canada Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters